缺失的环节:在多模式瘤学时代整合干预性疼痛管理
Alberto Corriero1, Mariateresa Giglio2, Rossana Soloperto3,4
1Department of Interdisciplinary Medicine - ICU and Pain Therapy Unit, University of Bari Aldo Moro, Piazza G. Cesare 11, 70124, Bari, Italy. alberto.corriero@gmail.com.
Pain and therapy
|June 17, 2025
概括
与癌症相关的疼痛需要比阿片类药物更好的管理. 干预性疼痛管理 (IPM) 提供了有效的缓解,副作用较少,但需要通过技术和主动护理改进.
科学领域:
- 在瘤学瘤学.
- 疼痛医学 医学 疼痛医学
- 干预性放射学 干预性放射学
背景情况:
- 癌症相关疼痛 (CrP) 显著影响患者的生活质量.
- 阿片类药物是标准的,但有副作用和耐受性等局限性.
- 多模式治疗计划是有效的CrP管理所必需的.
研究的目的:
- 突出CrP的介入性疼痛管理 (IPM) 的好处.
- 解决阻碍IPM使用的障碍.
- 为CrP提出一个主动的,技术集成的方法.
主要方法:
- 审查当前的CrP管理策略.
- 讨论干预性疼痛管理 (IPM) 技术 (神经阻塞,神经溶解,神经调节,脑内药物输送).
- 探索技术进步 (人工智能,自动推) 以改善对IPM的访问.
主要成果:
- 与阿片类药物相比,IPM提供有效的疼痛缓解,并减少了副作用.
- 不充分利用IPM与推迟转诊和缺乏意识有关.
- 技术创新可以促进早期干预和个性化治疗.
结论:
- 转向积极的模式,在癌症治疗中早期整合IPM至关重要.
- 技术进步和跨学科合作可以增强癌症疼痛管理.
- 未来的战略应专注于及时有效地缓解耐火性癌症疼痛.
相关概念视频
Analgesia and Pain Management
823
Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
823
Treatment Resistant Cancers
3.4K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.4K
Combination Therapies and Personalized Medicine
5.1K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.1K
Inflammatory Bowel Disease V: Surgical Management
226
Surgical interventions for inflammatory bowel disease (IBD), which includes ulcerative colitis and Crohn's disease, are essential in managing symptoms and addressing complications. The selection of surgical procedures is contingent upon the specific conditions and complications that stem from these illnesses.
Here are some common surgical interventions for IBD:
Here are some common surgical interventions for IBD:
226
Peripheral Artery Disease III: Interprofessional Care
35
Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
35
Chronic Pancreatitis II: Collaborative Care
133
The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
Assessment:
133


